Currently, there are 312.47M common shares owned by the public and among those 295.68M shares have been available to trade.
The company’s stock has a 5-day price change of 27.55% and 193.32% over the past three months. QBTS shares are trading 1387.40% year to date (YTD), with the 12-month market performance up to 124.88% higher. It has a 12-month low price of $0.75 and touched a high of $19.76 over the same period. QBTS has an average intraday trading volume of 67.99 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 19.17%, 22.78%, and 145.40% respectively.
Institutional ownership of D-Wave Quantum Inc (NYSE: QBTS) shares accounts for 29.17% of the company’s 312.47M shares outstanding.
It has a market capitalization of $5.90B and a beta (3y monthly) value of 1.40. The earnings-per-share (ttm) stands at -$0.60. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.09% over the week and 7.12% over the month.
Analysts forecast that D-Wave Quantum Inc (QBTS) will achieve an EPS of -0.06 for the current quarter, -0.05 for the next quarter and -0.19 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.06 while analysts give the company a high EPS estimate of -0.06. Comparatively, EPS for the current quarter was -0.11 a year ago. Earnings per share for the fiscal year are expected to increase by 56.84%, and 4.95% over the next financial year. EPS should grow at an annualized rate of 32.49% over the next five years, compared to -0.61% over the past 5-year period.
Looking at the support for the QBTS, a number of firms have released research notes about the stock. Cantor Fitzgerald stated their Overweight rating for the stock in a research note on July 02, 2025, with the firm’s price target at $20. B. Riley Securities coverage for the D-Wave Quantum Inc (QBTS) stock in a research note released on July 25, 2024 offered a Buy rating with a price target of $3. Needham was of a view on April 08, 2024 that the stock is Buy, while Piper Sandler gave the stock Overweight rating on October 19, 2022, issuing a price target of $12. ROTH Capital on their part issued Buy rating on August 30, 2022.
